Dn B Asset Management As Axsome Therapeutics, Inc. Transaction History
Dn B Asset Management As
- $25.3 Billion
- Q3 2025
A detailed history of Dn B Asset Management As transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 101,981 shares of AXSM stock, worth $14.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
101,981
Previous 61,528
65.75%
Holding current value
$14.2 Million
Previous $7.18 Million
72.59%
% of portfolio
0.05%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
410Shares Held
38.5MCall Options Held
771KPut Options Held
578K-
Vanguard Group Inc Valley Forge, PA4.18MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$461 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.33MShares$186 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY1.12MShares$156 Million1.82% of portfolio
-
Macquarie Group LTD Australia, C31.08MShares$151 Million0.16% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...